WO2013073827A1 - Composition contenant des minéraux naturels et l'eau extraite à partir de ceux-ci en tant que principes actifs - Google Patents

Composition contenant des minéraux naturels et l'eau extraite à partir de ceux-ci en tant que principes actifs Download PDF

Info

Publication number
WO2013073827A1
WO2013073827A1 PCT/KR2012/009590 KR2012009590W WO2013073827A1 WO 2013073827 A1 WO2013073827 A1 WO 2013073827A1 KR 2012009590 W KR2012009590 W KR 2012009590W WO 2013073827 A1 WO2013073827 A1 WO 2013073827A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
talc
mineral
dolomite
cancer
Prior art date
Application number
PCT/KR2012/009590
Other languages
English (en)
Korean (ko)
Inventor
권태동
Original Assignee
Kwon Tae Dong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020110118286A external-priority patent/KR101199897B1/ko
Priority claimed from KR1020110118267A external-priority patent/KR101199896B1/ko
Priority claimed from KR1020110118280A external-priority patent/KR101199895B1/ko
Application filed by Kwon Tae Dong filed Critical Kwon Tae Dong
Priority to CN201280051514.9A priority Critical patent/CN104039332A/zh
Publication of WO2013073827A1 publication Critical patent/WO2013073827A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition pharmaceutique pour la prévention et le traitement du diabète, laquelle composition pharmaceutique contient des minéraux naturels et l'eau extraite à partir de ceux-ci en tant que principes actifs. Plus particulièrement, au moins un minéral choisi dans le groupe consistant en lizardite, antigorite, brucite, magnésite, dolomite, talc, clinochlore, calcite, hornblende et phologopite, et l'eau qui est extraite à partir des minéraux et dont la qualité est appropriée pour les normes d'eau potable, contiennent une quantité significativement importante d'éléments des terres rares, génèrent une quantité importante de rayonnement dans l'infrarouge lointain et d'anions pour améliorer et favoriser la santé, bloquent différentes formes de rayonnement dangereux, tels que des ondes de veines d'eau et des ondes électromagnétiques, stimulent l'activité du métabolisme, et ont les effets d'inhibition et de réduction remarquables du glucose dans le sang pour le diabète de type 1 et le diabète de type 2. Par conséquent, le minéral et l'eau extraite à partir de celui-ci peuvent être utilisés de manière efficace dans le développement de : une composition pharmaceutique en vue de prévenir et de traiter le diabète, et une composition d'aliment de santé ayant le même objectif ; une composition pharmaceutique en vue de prévenir et de traiter le cancer en raison du fait qu'elle a les effets remarquables d'empêcher les tumeurs de croître ou de produire des métastases dans le cas de la leucémie, du cancer colorectal, du cancer de l'estomac, du cancer du poumon et du cancer de la peau, et une composition d'aliment de santé ayant le même objectif ; et une composition pharmaceutique à des fins antibactériennes en raison du fait qu'elle a des effets hautement antibactériens contre E. coli et Pseudomonas aeruginosa, ainsi qu'une composition à appliquer de manière externe sur la peau et une composition cosmétique ayant le même objectif.
PCT/KR2012/009590 2011-11-14 2012-11-14 Composition contenant des minéraux naturels et l'eau extraite à partir de ceux-ci en tant que principes actifs WO2013073827A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201280051514.9A CN104039332A (zh) 2011-11-14 2012-11-14 含有天然矿物及其提取物作为有效成分的组合物

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR10-2011-0118280 2011-11-14
KR1020110118286A KR101199897B1 (ko) 2011-11-14 2011-11-14 천연 광물 및 이의 용해물을 유효성분으로 함유하는 암 예방 및 치료용 조성물
KR1020110118267A KR101199896B1 (ko) 2011-11-14 2011-11-14 천연 광물 및 이의 용해물을 유효성분으로 함유하는 항균용 약학적 조성물
KR1020110118280A KR101199895B1 (ko) 2011-11-14 2011-11-14 천연 광물 및 이의 용해물을 유효성분으로 함유하는 당뇨병 예방 및 치료용 조성물
KR10-2011-0118267 2011-11-14
KR10-2011-0118286 2011-11-14

Publications (1)

Publication Number Publication Date
WO2013073827A1 true WO2013073827A1 (fr) 2013-05-23

Family

ID=48429840

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/009590 WO2013073827A1 (fr) 2011-11-14 2012-11-14 Composition contenant des minéraux naturels et l'eau extraite à partir de ceux-ci en tant que principes actifs

Country Status (2)

Country Link
CN (1) CN104039332A (fr)
WO (1) WO2013073827A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109320200A (zh) * 2017-08-01 2019-02-12 崔光浩 一种对人体有益的合成物及其制造方法
CN109419007A (zh) * 2017-08-26 2019-03-05 河北乐居科技有限公司 一种液态发酵法制备负离子甲壳素水剂治疗糖尿病的方法
CN110279711A (zh) * 2019-07-29 2019-09-27 深圳市砾石新配方科技发展有限公司 一种多功效药石配方
CN111012804B (zh) * 2019-12-16 2022-05-17 南京大学 益生菌矿物材料复合制剂、矿物材料在制备抑制恶性肿瘤生长药物中的应用
CN112022872A (zh) * 2020-09-04 2020-12-04 上海中医药大学 磐龙墨玉提取物及其制备方法和用途
CN112408408A (zh) * 2020-12-02 2021-02-26 吉林大学 一种含有活性云母的组合物在抑菌活性中的应用
TWI805128B (zh) * 2021-12-15 2023-06-11 顏崇恩 由能量材料配方萃取鎂元素的方法及其應用於舒緩高血壓症狀的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2755557B2 (ja) * 1994-07-11 1998-05-20 ロレアル 洗浄性の化粧用組成物およびその使用方法
KR20030076537A (ko) * 2003-09-03 2003-09-26 (주)서봉바이오베스텍 면역기능을 갖는 게르마늄 복합광물과 면역기능증진제로서의 용도
JP2004323641A (ja) * 2003-04-23 2004-11-18 Nobuhide Maeda 機能性材料およびそれを用いた用途
KR20090114270A (ko) * 2008-04-29 2009-11-03 순천향대학교 산학협력단 무좀의 예방 또는 치료용 미네랄 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100395213C (zh) * 2005-09-13 2008-06-18 东华大学 具有负离子发射功能的陶瓷材料及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2755557B2 (ja) * 1994-07-11 1998-05-20 ロレアル 洗浄性の化粧用組成物およびその使用方法
JP2004323641A (ja) * 2003-04-23 2004-11-18 Nobuhide Maeda 機能性材料およびそれを用いた用途
KR20030076537A (ko) * 2003-09-03 2003-09-26 (주)서봉바이오베스텍 면역기능을 갖는 게르마늄 복합광물과 면역기능증진제로서의 용도
KR20090114270A (ko) * 2008-04-29 2009-11-03 순천향대학교 산학협력단 무좀의 예방 또는 치료용 미네랄 조성물

Also Published As

Publication number Publication date
CN104039332A (zh) 2014-09-10

Similar Documents

Publication Publication Date Title
WO2013073827A1 (fr) Composition contenant des minéraux naturels et l'eau extraite à partir de ceux-ci en tant que principes actifs
JP5654731B2 (ja) 藍草抽出物粉末とその製造方法及びその藍草抽出物粉末の用途
CN104432012B (zh) 一种石斛复合超微粉及其制备方法
CN110946196B (zh) 木姜叶柯冲剂及制备方法
EP2630961B1 (fr) Agent favorisant la guérison d'une blessure d'un organisme vivant
KR101976999B1 (ko) 복합 효소를 이용한 도라지 추출물 제조 방법 및 이를 포함하는 항산화, 미백 또는 주름개선용 조성물
KR20060108225A (ko) 진세노시드 Ｒｇ５의 함량을 증대시키기 위한 가공인삼제조방법 및 이를 함유하는 조성물
KR100635025B1 (ko) 식초를 이용한 인삼 제제 및 이의 제조방법
KR102161179B1 (ko) 홍차줄기 추출물을 함유하는 항산화성 조성물
TW201216972A (en) Metal ion nanoclusters
KR101199895B1 (ko) 천연 광물 및 이의 용해물을 유효성분으로 함유하는 당뇨병 예방 및 치료용 조성물
WO2013015519A1 (fr) Composition antioxydante contenant un isorhamnétine-3-glucoside-7-rhamnoside séparé de feuilles d'hippophae rhamnoides à titre de principe actif
KR101976998B1 (ko) 초고압 효소처리를 이용한 도라지 추출물 제조 방법 및 이를 포함하는 항산화 또는 α-글루코시다제 저해 활성을 갖는 조성물
KR101199897B1 (ko) 천연 광물 및 이의 용해물을 유효성분으로 함유하는 암 예방 및 치료용 조성물
JP2010184886A (ja) 新規化合物
KR20080043816A (ko) 느티만가닥 버섯 유래 추출물의 제조 방법
KR20200082268A (ko) 인삼 발효 추출물을 유효성분으로 함유하여 황색포도상구균에 대한 항균 활성을 갖는 조성물
KR101063351B1 (ko) 비타민나무 추출물 및 이의 분획물
KR100530578B1 (ko) 항균활성을 갖는 키토산, 키토산올리고당 및 자몽종자추출물을 함유한 약학조성물
KR102160868B1 (ko) 노네인을 유효성분으로 포함하는 항알러지, 아토피 피부염 개선, 또는 피부 재생용 조성물
KR20150120741A (ko) 감 껍질, 감 과육, 감잎 및 고욤잎의 혼합물을 유효성분으로 함유하는 아토피 피부염 예방 또는 개선용 조성물
KR20160068316A (ko) 황벽 추출물을 포함하는 미백용 조성물
KR102104518B1 (ko) 대추잎 추출물, 또는 대추잎 및 가시오갈피의 혼합 추출물을 유효성분으로 함유하는 항진균용 조성물
JP5008813B2 (ja) クビレヅタ抽出物を含有する抗皮膚癌剤
KR20130038526A (ko) 대추 추출물과 홍삼 추출물을 이용한 에센스 및 그 제조방법

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12849506

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12849506

Country of ref document: EP

Kind code of ref document: A1